QGEN News and Press, Qiagen N.V.

2026-03-02 15:38:11 ET More on Qiagen Qiagen N.V. (QGEN) Presents at TD Cowen 46th Annual Health Care Conference Transcript Qiagen N.V. (QGEN) Q4 2025 Earnings Call Transcript Qiagen N.V. 2025 Q4 - Results - Earnings Call Presentation Qiagen targets 9% growth...

2026-03-02 11:37:52 ET Qiagen N.V. (QGEN) TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM EST... Read the full article on Seeking Alpha For further details see: Qiagen N.V. (QGEN) Presents at TD Cowen 46th Annual Health Care Conference Transcript

New chemistry reduces barriers to scaling single-cell studies across research settings Launch planned for March 2026, available across Evercode Whole Transcriptome product line Parse Biosciences, a QIAGEN company (NYSE: QGEN, Frankfurt Prime Standard: QIA), and the leading p...

2026-02-05 16:04:23 ET from Jefferies issued a price target of $59.00 for QGEN on 2026-02-05 20:44:14. The adjusted price target was set to $59.00. At the time of the announcement, QGEN was trading at $51.23. The overall price target consensus is at $54.50 with high pric...

2026-02-05 14:45:38 ET More on Qiagen Qiagen N.V. (QGEN) Q4 2025 Earnings Call Transcript Qiagen N.V. 2025 Q4 - Results - Earnings Call Presentation Qiagen: Takeover Optionality With A High-Quality Consumables Platform Qiagen Q4 2025 Earnings Preview ...

2026-02-05 14:44:26 ET Qiagen N.V. (QGEN) Q4 2025 Earnings Call February 5, 2026 9:30 AM EST Company Participants Daniel Wendorff - VP & Head of Investor Relations Thierry Bernard - CEO, MD & Member of Management Board Roland Sackers - CFO, MD & Member ...

2026-02-04 16:48:24 ET Qiagen press release ( QGEN ): Q4 Non-GAAP EPS of $0.62 in-line. Revenue of $540M (+3.6% Y/Y) beats by $11.51M . 2026 outlook: Net sales growth of at least 5% CER with growth pillars expected to contribute about $1.64 billion CER (~+9% CE...

Q4 2025: Net sales of $540 million (+4% at actual rates, +1% at constant exchange rates (CER)); diluted EPS of $0.49 and adjusted diluted EPS of $0.62 Net sales growth of 1% CER ahead of outlook for steady results vs. Q4 2024, adjusted diluted EPS of $0.62 CER ahead of outlook of about $0...

Central Garden & Pet Company (CENT) is expected to report $0.11 for Q1 2026 Eli Lilly and Company (LLY) is expected to report $6.99 for Q4 2025 The Ensign Group Inc. (ENSG) is expected to report $1.59 for Q4 2025 McKesson Corporation (MCK) is expected to report $9.31 for Q3 2026 ...

QIAsprint Connect marks entry into high-throughput sample processing, enabling labs to scale workflows with flexible protocols, compact design and sustainability-focused features QIAGEN also to showcase new automation systems: QIAsymphony Connect for clinical applications and QIAmini ...